- Nachrichtendetail
-
11.03.2024 14:06:55 - dpa-AFX: *ASTELLAS PHARMA RECEIVES FDA EXCLUSIVITIES FOR CRESEMBA IN PEDIATRIC PATIENTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
ASTELLAS PHARMA INC. | 856273 | Frankfurt | 8,764 | 21.06.24 09:59:34 | +0,262 | +3,08% | 8,712 | 9,148 | 8,764 | 8,502 |
